Benzinga | Jan 7, 2022 01:01PM EST

BMO Capital Upgrades National Health Investors to Outperform, Announces $68 Price Target

BMO Capital analyst John Kim upgrades National Health Investors (NYSE:NHI) from Market Perform to Outperform and announces $68 price target.